Thought leadership

Last year, the biotech industry faced numerous roadblocks which hindered progress in delivering innovative medicines to patients. The industry had to work through geopolitical tensions and unpredictable local capital markets, which brought about existing challenges to the fore, such as a lack of access to capital and stringent regulatory frameworks. Despite these obstacles, the industry…

An interview with Altair Da Silva, Senior VP of Clinical Trial Patient Recruitment at Spectrum Science, our US partners.  When planning clinical trials, it may be tempting to leave everything up to the Contract Research Organization (CRO), but in today’s extremely competitive recruitment landscape, sponsors must think outside of the traditional recruitment parameters to prevent…

We asked our partner agencies from the GHMC Network for their perspectives on healthcare communication trends and opportunities in 2023. Here’s a look at what’s unfolding in Asia Pacific, North America, Europe, and Latin America. GHMC – Global Health and Marketing Communications – is a robust global network of independent healthcare agencies where health, science,…

This is a contributed article by Professor Derek Connolly, Consultant Cardiologist and the Director of Research and Development at Birmingham City Hospital and the Clinical lead for cardiac care for the local integrated Care System. He is an Honorary clinical associate Professor at Aston medical school and Senior Clinical Lecturer at the Institute of Cardiovascular…

This is a contributor article by Dr Jeremy Lim, Chief Executive Officer and Co-founder of AMILI. We live among millions of bacteria that have made themselves comfortable on, around, and inside of us. They greatly outnumber our human cells. One could say that it’s a bacterial world and we merely live in it.   What is…

The last two years have been a rollercoaster for people with Alzheimer’s Disease (AD) and their families. The pandemic has had an impact…